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Purpose/Objective: Very limited information on how gliomas respond 
to chemo-radiation therapy (RCX) is available. Recent studies have 
shown the diagnostic potential of Positron Emission Tomography (PET) 
with O-(2-18F-fluoroethyl)-l-tyrosine (FET) to discriminate glioblastoma 
from healthy tissue. The aim of this study was to evaluate the changes 
in FET uptake during RCX based on FET-PET scans.  
Materials and Methods: Sixteen consecutive patients with primary 
glioblastoma multiforme (GBM), WHO grade IV, were treated with 
surgery and subsequent RCX with a standard dose of 60 Gy in 30 
fractions and concurrent temozolomide (TMZ). Two FET-PET 
examinations, denoted FET1 and FET2, respectively, were performed 
once before RCX and once after approximately 20 fractions (median: 
19, range 13-23). A biological tumor volume was definedin both scans 
(BTV1 and BTV2, respectively) using a threshold-based delineation, 
including tissue with a tumor-to-background ratio (TBR) of at least 
1.6. Background was determined by contouring a large region 
contralateral to the tumor and averaging all voxels with an uptake 
higher than 70% of the maximum. FET2 was rigidly registered to FET1 
using the CT scan in order to compare uptake parameters and spatial 
change of the positive volume. A maximum expansion (ME) in BTV was 
calculated for each patient. 
Results: After approximately 40 Gy of RCX, a significantly higher 
background uptake of FET was observed (p =0.0025,paired t-test). The 
median change in TBRmax and TBRmean were -2.2% and -1.1% (range: -27 
to +16 and -11 to +12), respectively. Investigation of the spatial 
change in FET-uptake from the 1st to the 2nd scan revealed a median 
displacement of the maximum voxel (TBRmax) of 10.4 mm (range: 1.8-
53). A significant spatial change in tumor volume is illustrated in 
figure 1. The margin required to include BTV at the time of FET2 
ranged from 3.5 to 37 mm (median: 8.2). 
 
  
Figure 1: Y-axis: Number of tumours within margin, X-axis: Margin 
added to the first FET scan (mm) 
 
Conclusions: The results show a significantly higher uptake in healthy 
tissue of FET during RCX, affecting the background estimate. For the 
16 patients included in this study, a distinct spatial change in FET-
uptake in glioblastoma during RCX was observed, assuming that the 
TBR of 1.6 is also usable at the time of FET2. The analysis showed a 
large variation of the position of the voxel with high uptake during the 
course of therapy. 
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Purpose/Objective: Definition of gross tumour volume (GTV) isof 
great importance for radiation therapy. Definition of GTV is 
performed by manual contouring on image slices from computerized 
tomography (CT). The GTV contours are vulnerable to intra- and 
intercontourer variation. It is possible to reduce the variation by 
providing an automatic segmentation estimated from the image. The 
literature consists of approaches using differing algorithms and image 
features for the segmentation. In this study we investigated the 
implication of using different feature estimation parameters for 
segmentation to improve robustness of the approach. 
Materials and Methods: The data set consisted of 40 patients. All 
patients had been diagnosed with hypopharynx cancer and were 
referred for radiation therapy. For each patient a PET/CT scan was 
available along with the contour of the GTV. These patients were 
divided into a training and test set consisting of 20 patients each. 
Image features were estimated using 4 different patch sizes, 3 ranges 
of values and 3 discretisation levels for both CT and PET. Tumour and 
background specific features were extracted from the training set. 
The training features were used to construct a tumour classifier using 
the adaboost algorithms. Repeated use of the training set using 
bootstrap methods ensured arobust classifier which was not 
influenced by outliers.  
Using the classifier it was possible to extract both GTV and evaluate it 
against the manual contour of the test set using dice coefficient. The 
feature based segmentation was compared with the results of 
threshold segmentation on the PET image using a paired t-test, p-
values of less than 0.05 were considered significant. 
Results: Using the new feature approach it was possible to extract 
automatic GTV contours. The mean dice coefficient for the different 
feature settings varied from 0.65-0.80. The highest mean dice 
coefficient was achieved using a 3x3x3 patch with an absolute range 
of values ranging from -125to 250 HU on CT and 0 to 5 SUV on PET. 
There was a significant difference between the feature segmentation 
with the lowest and highest overlap (p<0.01). 
Using threshold segmentation on the PET images it was possible to 
achieve a mean dice coefficient of 0.72. Making a paired t-test 
between the feature segmentation with the highest mean dice 
coefficient and the threshold segmentation showed a significant 
different (p=0.03). 
Conclusions: It was shown that it is possible to achieve a robust 
segmentation using image features. There is a significant difference 
between different feature estimation approaches. Image features 
produced significantly better segmentations than conventional PET-
thresholding. 
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Purpose/Objective: To analyze the recurrence pattern in patients 
with cancer of the esophagus or gastro-esophageal junction treated 
with either preoperative chemoradiotherapy plus surgery (CRT + S) or 
surgery alone (S) within the phase II and III CROSS trials. 
Materials and Methods: Relapse pattern in relation to the radiation 
fields was analyzed in patients from the previously published non-
randomized CROSS I trial (n=54) and the subsequent randomized 
CROSS II trial (n=368). Multimodal treatment consisted of 5 weekly 
courses of Paclitaxel (50 mg/m2) and Carboplatin (AUC = 2) combined 
with a concurrent radiation dose of 41.1 Gy in 23 fractions of 1.8 Gy. 
The radiation fields included the primary tumor, all pathologic lymph 
nodes and an elective lymph node area of 4 cm in craniocaudal 
direction from the primary tumor. 
Results: Between 2001 and 2008 a total of 422 patients were 
included, of whom 418 were evaluable. Mean age was 60 years (36-
79), histology was adenocarcinoma in 75% and squamous cell 
carcinoma in 23%. A total of 374 patients underwent resection, 161 
(86%) of patients allocated for S and 213 (92%) for CRT+S. After a 
minimum follow-up of 24 months and a median follow-up of 45 months 
for surviving patients, the overall recurrence rate in the S-arm was 
92/161 (58%) and 74/213 (35%) in the CRT+S-arm. Preoperative CRT 
reduced locoregional recurrences (LRR) from 34 to 14% (p<0.0001) and 
